Vanda Pharmaceuticals (VNDA) Gains with Q4 Results Due

Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) rose 3.7% to $14.15. Vanda Pharmaceuticals is expected to announce Q4 financial results on February 15. Share volume was 519,000, compared to an all-day average of 574,000